Panambí Ventures

Overview

Panambí Ventures is a venture capital firm dedicated to advancing mental health and well-being in Latin America through innovative and disruptive approaches. The firm focuses on investing in early-stage companies that utilize psychedelics and entheogens as therapeutic treatments, aiming to address mental health issues in the region. By combining science, technology, and nature, Panambí Ventures seeks to create a holistic ecosystem that promotes human well-being. The firm's investment strategy encompasses various sectors, including biotechnology, pharmaceuticals, digital health, artificial intelligence, data analysis, medical devices, research and development, education, wellness, neuroscience, pharmacology, and psychiatry. Panambí Ventures operates across multiple stages, primarily focusing on seed and early-stage investments. Geographically, the firm concentrates its efforts in Latin American countries such as Argentina, Brazil, Mexico, Colombia, Chile, Ecuador, Peru, Uruguay, Paraguay, Bolivia, Costa Rica, Panama, Guatemala, Honduras, El Salvador, Nicaragua, Cuba, Dominican Republic, Jamaica, and Trinidad and Tobago. Panambí Ventures is committed to fostering a network that connects research with investment, bridging the gap between traditional and contemporary medicine. The firm emphasizes trust, awareness, and respect in its operations, ensuring that investments are made in safe and reliable environments. By supporting developments that work with seriousness, efficacy, and safe protocols, Panambí Ventures aims to enhance the healing power of nature and contribute to the global conversation on mental health and well-being.

Investment Focus

• Companies focused on mental health and well-being through innovative and disruptive approaches
• Early-stage companies utilizing psychedelics and entheogens as therapeutic treatments
• Businesses operating in Latin American countries
• Startups in sectors such as biotechnology, pharmaceuticals, digital health, artificial intelligence, data analysis, medical devices, research and development, education, wellness, neuroscience, pharmacology, and psychiatry